Altimmune (ALT) Other Operating Expenses (2010 - 2023)
Altimmune's (ALT) quarterly Other Operating Expenses came in at $12.4 million in Q4 2023, up 276.33% on a QoQ basis from $3.3 million in Q4 2021.
Altimmune (ALT) Other Operating Expenses (2010 - 2023) Analysis & Trends
Altimmune (ALT) has 12 years of Other Operating Expenses data on file, last reported at $12.4 million in Q4 2023.
- On a quarterly basis, Other Operating Expenses changed N/A year-over-year to $12.4 million in Q4 2023; TTM through Sep 2024 was $12.4 million, a N/A change from a year earlier, with the FY2023 full-year figure at $12.4 million, changed N/A from the prior year.
- Other Operating Expenses for Q4 2023 stood at $12.4 million, up from $3.3 million in the prior quarter.
- Over the last five years, Other Operating Expenses for ALT reached as high as $12.4 million in Q4 2023 and fell as low as $1.0 million in Q3 2019.
- Historically, Other Operating Expenses has averaged $6.2 million across 3 years, with a median of $5.7 million in 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Altimmune | 7.96 Mn | 7.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 12.42 Mn |
| Dec 31, 2021 | 3.30 Mn |
| Jun 30, 2021 | 8.07 Mn |
| Sep 30, 2019 | 1.00 Mn |
| Dec 31, 2018 | 24.45 Mn |
| Mar 31, 2018 | 490,676.00 |
| Dec 31, 2017 | 9.32 Mn |
| Sep 30, 2017 | 26.60 Mn |
| Dec 31, 2016 | 94.61 Mn |
| Sep 30, 2016 | 113.57 Mn |
| Jun 30, 2016 | 8.90 Mn |
| Mar 31, 2016 | 37,701.00 |
| Mar 31, 2015 | 37,106.00 |
| Dec 31, 2014 | 36,686.00 |
| Sep 30, 2014 | 37,125.00 |
| Jun 30, 2014 | 36,208.00 |
| Mar 31, 2014 | 39,939.00 |
| Dec 31, 2013 | 43,438.00 |
| Sep 30, 2013 | 44,593.00 |
| Jun 30, 2013 | 41,854.00 |